Neurourology and Urodynamics

Cover image for Vol. 33 Issue S3

Supplement: Best Practice in the use of OnabotulinumtoxinA (BOTOX®) to Optimize Patient Outcomes in Overactive Bladder

July 2014

Volume 33, Issue S3

Pages S1–S37

  1. Review Articles

    1. Top of page
    2. Review Articles
    1. Allergan provided suggestions to Newton Healthcare Communications, Oxford, UK (Newton) for topic ideas and authors of the manuscripts included in this supplement. For each manuscript, Allergan had the opportunity to review the final version and provide comments; however, the authors maintained complete control over the content. The authors determined final content, and all authors read and approved the final manuscript. No payments were made to the authors for the writing of this manuscript. Arthur Smyth Medina, David Hallett and Harriet Penny of Newton provided medical writing and editorial support to the authors of Chapters 1, 2, 5 and 6. For each of these chapters, the topics, structure and argument of the article were agreed by the author(s) and based on this discussion, the medical writer drafted an outline that was shared for discussion. Newton subsequently prepared drafts and figures, which were reviewed, and commented upon, by all authors. Allergan paid Newton for this work. Allergan paid Neurourology and Urodynamics (Wiley) for publishing this supplement